While in the vast majority of cases fluorescence in biological
matter has been attributed to aromatic or conjugated groups, peptides
associated with neurodegenerative diseases, such as Alzheimer’s,
Parkinson’s, or Huntington’s, have been recently shown
to display an intrinsic visible fluorescence even in the absence of
aromatic residues. This has called the attention of researchers from
many different fields, trying to understand the origin of this peculiar
behavior and, at the same time, motivating the search for novel strategies
to control the optical properties of new biophotonic materials. Today,
after nearly 15 years of its discovery, there is a growing consensus
about the mechanism underlying this phenomenon, namely, that electronic
interactions between non-optically active molecules can result in
supramolecular assemblies that are fluorescent. Despite this progress,
many aspects of this phenomenon remain uncharted territory. In this
Perspective, we lay down the state-of-the-art in the field highlighting
the open questions from both experimental and theoretical fronts in
this fascinating emerging area of non-aromatic fluorescence.